0	0	1998-09-22	CD	O	B-NP	B-Num
0	1	18	CD	O	I-NP	B-Num
0	2	:	:	O	O	I-Num
0	3	16	CD	O	B-NP	I-Num
0	4	&	CC	O	O	O
0	5	HT	NNP	O	B-NP	O
0	6	;	:	O	O	O
0	7	&	CC	O	O	O
0	8	HT	NNP	O	B-NP	O
0	9	;	:	O	O	O

1	0	ATLANTA_A	NNP	O	O	O
1	1	new	JJ	O	B-NP	O
1	2	treatment	NN	O	I-NP	O
1	3	demonstrated	VBD	O	B-VP	O
1	4	Tuesday	NNP	O	B-NP	B-Date
1	5	by	IN	O	B-PP	O
1	6	a	DT	O	B-NP	O
1	7	Georgia	NNP	O	I-NP	B-LocStat
1	8	company	NN	O	I-NP	B-OrgCorp
1	9	promises	VBZ	O	B-VP	O
1	10	to	TO	O	I-VP	O
1	11	help	VB	O	I-VP	O
1	12	women	NNS	O	B-NP	O
1	13	control	VBP	O	B-VP	O
1	14	incontinence	NN	O	B-NP	B-Medical
1	15	by	IN	O	B-PP	O
1	16	merely	RB	O	O	O
1	17	sitting	VBG	O	B-VP	O
1	18	in	IN	O	B-PP	O
1	19	a	DT	O	B-NP	O
1	20	special	JJ	O	I-NP	O
1	21	chair	NN	O	I-NP	O
1	22	twice	RB	O	B-NP	O
1	23	a	DT	O	I-NP	O
1	24	week	NN	O	I-NP	O
1	25	for	IN	O	B-PP	O
1	26	eight	CD	O	B-NP	B-Num
1	27	weeks	NNS	O	I-NP	O
1	28	.	.	O	O	O

2	0	The	DT	O	B-NP	O
2	1	Neocontrol	NNP	O	I-NP	O
2	2	Pelvic	NNP	O	I-NP	O
2	3	Floor	NNP	O	I-NP	O
2	4	Therapy	NNP	O	I-NP	B-Peop
2	5	System	NNP	O	I-NP	I-Peop
2	6	COMMA	COMMA	O	O	O
2	7	developed	VBD	O	B-VP	O
2	8	by	IN	O	B-PP	O
2	9	Neotonus	NNP	O	B-NP	O
2	10	Inc.	NNP	O	I-NP	O
2	11	and	CC	O	O	O
2	12	Emory	NNP	O	B-NP	B-OrgUniv
2	13	University	NNP	O	I-NP	I-OrgUniv
2	14	-LBR-	-LBR-	O	O	O
2	15	Ga.	NNP	O	O	O
2	16	-RBR-	-RBR-	O	O	O
2	17	and	CC	O	O	O
2	18	Georgia	NNP	O	B-NP	O
2	19	Tech	NNP	O	I-NP	O
2	20	researchers	NNS	O	I-NP	B-ProfTitle
2	21	COMMA	COMMA	O	O	O
2	22	uses	VBZ	O	B-VP	O
2	23	pulsed	JJ	O	B-NP	O
2	24	magnetic	JJ	O	I-NP	O
2	25	therapy	NN	O	I-NP	B-Medical
2	26	to	TO	O	B-VP	O
2	27	exercise	VB	O	I-VP	B-Sport
2	28	and	CC	O	O	O
2	29	strengthen	VBP	O	B-VP	O
2	30	pelvic	JJ	O	B-NP	B-Medical
2	31	muscles	NNS	O	I-NP	O
2	32	that	IN	O	B-NP	O
2	33	control	VBP	O	B-VP	O
2	34	bladder	NN	O	B-NP	O
2	35	function	NN	O	I-NP	O
2	36	.	.	O	O	O

3	0	It	PRP	O	B-NP	O
3	1	is	VBZ	O	B-VP	O
3	2	being	VBG	O	I-VP	O
3	3	made	VBN	O	I-VP	O
3	4	available	JJ	O	O	O
3	5	first	JJ	O	O	B-Num
3	6	in	IN	O	B-PP	O
3	7	Atlanta	NNP	O	B-NP	B-LocCit
3	8	and	CC	O	O	O
3	9	will	MD	O	B-VP	O
3	10	be	VB	O	I-VP	O
3	11	rolled	VBN	O	I-VP	O
3	12	out	IN	O	O	O
3	13	nationwide	JJ	O	B-NP	O
3	14	next	JJ	O	I-NP	O
3	15	year	NN	O	I-NP	O
3	16	.	.	O	O	O

4	0	``	``	O	O	O
4	1	For	IN	O	B-PP	O
4	2	the	DT	O	B-NP	O
4	3	majority	NN	O	I-NP	O
4	4	of	IN	O	B-PP	O
4	5	patients	NNS	O	B-NP	O
4	6	COMMA	COMMA	O	O	O
4	7	it	PRP	O	B-NP	O
4	8	's	VBZ	O	B-VP	O
4	9	a	DT	O	B-NP	O
4	10	simple	JJ	O	I-NP	O
4	11	COMMA	COMMA	O	I-NP	O
4	12	safe	JJ	O	I-NP	O
4	13	and	CC	O	I-NP	O
4	14	painless	JJ	O	I-NP	O
4	15	treatmentCOMMA	NN	O	I-NP	O
4	16	''	''	O	O	O
4	17	said	VBD	O	B-VP	O
4	18	Dr.	NNP	O	B-NP	B-ProfTitle
4	19	Niall	NNP	O	I-NP	B-Peop
4	20	Galloway	NNP	O	I-NP	I-Peop
4	21	COMMA	COMMA	O	O	O
4	22	a	DT	O	B-NP	O
4	23	urologist	NN	O	I-NP	O
4	24	and	CC	O	I-NP	O
4	25	director	NN	O	I-NP	B-ProfTitle
4	26	of	IN	O	B-PP	O
4	27	the	DT	O	B-NP	O
4	28	Emory	NNP	O	I-NP	O
4	29	Continence	NNP	O	I-NP	O
4	30	Center	NNP	O	I-NP	O
4	31	.	.	O	O	O

5	0	``	``	O	O	O
5	1	Our	PP$	O	B-NP	O
5	2	studies	NNS	O	I-NP	O
5	3	show	VBP	O	B-VP	O
5	4	it	PRP	O	B-NP	O
5	5	works	VBZ	O	B-VP	O
5	6	.	.	O	O	O
5	7	''	''	O	O	O

6	0	Galloway	NNP	O	B-NP	B-Peop
6	1	helped	VBD	O	B-VP	O
6	2	develop	VB	O	I-VP	O
6	3	Neocontrol	NNP	O	B-NP	O
6	4	COMMA	COMMA	O	O	O
6	5	which	WDT	O	B-NP	O
6	6	was	VBD	O	B-VP	O
6	7	approved	VBN	O	I-VP	O
6	8	by	IN	O	B-PP	O
6	9	the	DT	O	B-NP	O
6	10	Food	NNP	O	I-NP	B-Food
6	11	and	CC	O	I-NP	O
6	12	Drug	NNP	O	I-NP	O
6	13	Administration	NNP	O	I-NP	O
6	14	in	IN	O	B-PP	O
6	15	June	NNP	O	B-NP	B-Date
6	16	COMMA	COMMA	O	O	O
6	17	and	CC	O	O	O
6	18	the	DT	O	B-NP	O
6	19	continence	NN	O	I-NP	O
6	20	center	NN	O	I-NP	O
6	21	is	VBZ	O	B-VP	O
6	22	treating	VBG	O	I-VP	O
6	23	45	CD	O	B-NP	B-Num
6	24	patients	NNS	O	I-NP	O
6	25	with	IN	O	B-PP	O
6	26	the	DT	O	B-NP	O
6	27	system	NN	O	I-NP	O
6	28	.	.	O	O	O

7	0	Neotonus	NNP	O	B-NP	B-Peop
7	1	will	MD	O	B-VP	O
7	2	be	VB	O	I-VP	O
7	3	licensing	VBG	O	I-VP	O
7	4	the	DT	O	B-NP	O
7	5	system	NN	O	I-NP	O
7	6	COMMA	COMMA	O	O	O
7	7	manufactured	VBN	O	B-VP	O
7	8	at	IN	O	B-PP	O
7	9	Design	NNP	O	B-NP	B-Org
7	10	and	CC	O	I-NP	O
7	11	Manufacturing	NNP	O	I-NP	O
7	12	Services	NNPS	O	I-NP	O
7	13	COMMA	COMMA	O	O	O
7	14	to	TO	O	B-PP	O
7	15	doctors	NNS	O	B-NP	B-ProfTitle
7	16	'	POS	O	B-NP	O
7	17	offices	NNS	O	I-NP	O
7	18	and	CC	O	I-NP	O
7	19	treatment	NN	O	I-NP	O
7	20	centers	NNS	O	I-NP	O
7	21	COMMA	COMMA	O	O	O
7	22	said	VBD	O	B-VP	O
7	23	Neotonus	NNP	O	B-NP	B-Peop
7	24	CEO	NNP	O	I-NP	I-Peop
7	25	and	CC	O	O	O
7	26	President	NNP	O	B-NP	B-ProfTitle
7	27	Tony	NNP	O	I-NP	B-Peop
7	28	J.	NNP	O	I-NP	I-Peop
7	29	Morris	NNP	O	I-NP	I-Peop
7	30	.	.	O	O	O

8	0	So	RB	O	O	O
8	1	far	RB	O	O	O
8	2	COMMA	COMMA	O	O	O
8	3	the	DT	O	B-NP	O
8	4	treatment	NN	O	I-NP	O
8	5	is	VBZ	O	B-VP	O
8	6	available	JJ	O	O	O
8	7	at	IN	O	B-PP	O
8	8	10	CD	O	B-NP	B-Num
8	9	metro	NN	O	I-NP	O
8	10	Atlanta	NNP	O	I-NP	B-LocCit
8	11	sites	NNS	O	I-NP	O
8	12	.	.	O	O	O

9	0	Some	DT	O	B-NP	O
9	1	insurance	NN	O	I-NP	O
9	2	may	MD	O	B-VP	O
9	3	cover	VB	O	I-VP	O
9	4	the	DT	O	B-NP	O
9	5	$1COMMA200	NN	O	I-NP	B-Money
9	6	to	TO	O	B-PP	O
9	7	$1COMMA500	NN	O	B-NP	B-Money
9	8	treatment	NN	O	I-NP	O
9	9	cost	NN	O	I-NP	O
9	10	.	.	O	O	O

10	0	About	IN	O	B-NP	O
10	1	85	CD	O	I-NP	B-NumPercent
10	2	percent	NN	O	I-NP	I-NumPercent
10	3	of	IN	O	B-PP	O
10	4	the	DT	O	B-NP	O
10	5	15	CD	O	I-NP	B-Num
10	6	million	CD	O	I-NP	B-Num
10	7	Americans	NNPS	O	I-NP	B-LangRace
10	8	afflicted	VBN	O	B-VP	O
10	9	by	IN	O	B-PP	O
10	10	incontinence	NN	O	B-NP	B-Medical
10	11	are	VBP	O	B-VP	O
10	12	women	NNS	O	B-NP	O
10	13	COMMA	COMMA	O	O	O
10	14	and	CC	O	O	O
10	15	that	IN	O	B-NP	O
10	16	's	POS	O	B-VP	O
10	17	why	WRB	O	O	O
10	18	Neotonus	NNP	O	B-NP	B-Peop
10	19	focused	VBD	O	B-VP	O
10	20	on	IN	O	B-PP	O
10	21	them	PRP	O	B-NP	O
10	22	COMMA	COMMA	O	O	O
10	23	Morris	NNP	O	B-NP	B-Peop
10	24	said	VBD	O	B-VP	O
10	25	.	.	O	O	O

11	0	Initial	JJ	O	B-NP	O
11	1	tests	NNS	O	I-NP	O
11	2	suggest	VBP	O	B-VP	O
11	3	the	DT	O	B-NP	O
11	4	treatment	NN	O	I-NP	O
11	5	also	RB	O	O	O
11	6	may	MD	O	B-VP	O
11	7	help	VB	O	I-VP	O
11	8	men	NNS	O	B-NP	O
11	9	who	WP	O	B-NP	O
11	10	've	VBP	O	B-VP	O
11	11	lost	VBN	O	I-VP	O
11	12	bladder	NN	O	B-NP	O
11	13	control	NN	O	I-NP	O
11	14	after	IN	O	B-PP	O
11	15	prostate	NN	O	B-NP	B-Jour
11	16	surgery	NN	O	I-NP	O
11	17	COMMA	COMMA	O	O	O
11	18	but	CC	O	O	O
11	19	so	RB	O	O	O
11	20	far	RB	O	O	O
11	21	the	DT	O	B-NP	O
11	22	treatment	NN	O	I-NP	O
11	23	is	VBZ	O	B-VP	O
11	24	approved	VBN	O	I-VP	O
11	25	only	RB	O	O	O
11	26	for	IN	O	B-PP	O
11	27	women	NNS	O	B-NP	O
11	28	.	.	O	O	O

12	0	The	DT	O	B-NP	O
12	1	most	RBS	O	I-NP	O
12	2	common	JJ	O	I-NP	O
12	3	causes	NNS	O	I-NP	O
12	4	of	IN	O	B-PP	O
12	5	pelvic	JJ	O	B-NP	B-Medical
12	6	muscle	NN	O	I-NP	B-Medical
12	7	weakness	NN	O	I-NP	I-Medical
12	8	are	VBP	O	B-VP	O
12	9	childbirth	NN	O	B-NP	O
12	10	COMMA	COMMA	O	I-NP	O
12	11	surgery	NN	O	I-NP	O
12	12	COMMA	COMMA	O	O	O
12	13	injury	NN	O	B-NP	B-Medical
12	14	or	CC	O	I-NP	O
12	15	hormonal	JJ	O	I-NP	B-Medical
12	16	changes	NNS	O	I-NP	O
12	17	during	IN	O	B-PP	O
12	18	menopause	NN	O	B-NP	B-Medical
12	19	.	.	O	O	O

13	0	With	IN	O	B-PP	O
13	1	the	DT	O	B-NP	O
13	2	Neocontrol	NNP	O	I-NP	O
13	3	system	NN	O	I-NP	O
13	4	COMMA	COMMA	O	O	O
13	5	women	NNS	O	B-NP	O
13	6	sit	VBP	O	B-VP	O
13	7	fully	RB	O	O	O
13	8	clothed	VBN	O	O	O
13	9	for	IN	O	B-PP	O
13	10	about	IN	O	B-NP	O
13	11	20	CD	O	I-NP	B-Num
13	12	minutes	NNS	O	I-NP	I-Num
13	13	twice	RB	O	I-NP	O
13	14	a	DT	O	I-NP	O
13	15	week	NN	O	I-NP	O
13	16	in	IN	O	B-PP	O
13	17	a	DT	O	B-NP	O
13	18	chair	NN	O	I-NP	O
13	19	that	DT	O	B-NP	O
13	20	has	VBZ	O	B-VP	O
13	21	magnetic	JJ	O	B-NP	O
13	22	technology	NN	O	I-NP	O
13	23	imbedded	VBD	O	B-VP	O
13	24	in	IN	O	B-PP	O
13	25	the	DT	O	B-NP	O
13	26	seat	NN	O	I-NP	O
13	27	.	.	O	O	O

14	0	Pulsating	VBG	O	O	O
14	1	magnetic	JJ	O	B-NP	O
14	2	fields	NNS	O	I-NP	O
14	3	induce	VB	O	B-VP	O
14	4	muscle	NN	O	B-NP	O
14	5	contractions	NNS	O	I-NP	O
14	6	in	IN	O	B-PP	O
14	7	the	DT	O	B-NP	O
14	8	pelvic	JJ	O	I-NP	B-Medical
14	9	floor	NN	O	I-NP	O
14	10	to	TO	O	B-VP	O
14	11	build	VB	O	I-VP	O
14	12	strength	NN	O	B-NP	O
14	13	.	.	O	O	O

15	0	The	DT	O	B-NP	O
15	1	patient	NN	O	I-NP	B-Medical
15	2	feels	VBZ	O	B-VP	O
15	3	her	PP$	O	B-NP	O
15	4	muscles	NNS	O	I-NP	O
15	5	tighten	VBP	O	B-VP	O
15	6	COMMA	COMMA	O	O	O
15	7	but	CC	O	O	O
15	8	experiences	VBZ	O	B-VP	O
15	9	no	DT	O	B-NP	O
15	10	pain	NN	O	I-NP	O
15	11	.	.	O	O	O

16	0	The	DT	O	B-NP	O
16	1	treatment	NN	O	I-NP	O
16	2	works	VBZ	O	B-VP	O
16	3	much	RB	O	O	O
16	4	as	IN	O	O	O
16	5	Kegel	NNP	O	B-NP	O
16	6	exercises	VBZ	O	B-VP	O
16	7	do	VBP	O	B-VP	O
16	8	.	.	O	O	O

17	0	Those	DT	O	B-NP	O
17	1	exercises	VBZ	O	B-VP	O
17	2	COMMA	COMMA	O	O	O
17	3	developed	VBD	O	B-VP	O
17	4	in	IN	O	B-PP	O
17	5	the	DT	O	B-NP	O
17	6	1950s	CD	O	I-NP	B-Date
17	7	by	IN	O	B-PP	O
17	8	Dr.	NNP	O	B-NP	B-ProfTitle
17	9	A.M.	NNP	O	I-NP	B-Peop
17	10	Kegel	NNP	O	I-NP	I-Peop
17	11	COMMA	COMMA	O	O	O
17	12	involve	VBP	O	B-VP	O
17	13	contracting	VBG	O	I-VP	B-ProfTitle
17	14	the	DT	O	B-NP	O
17	15	anal	NN	O	I-NP	B-Medical
17	16	sphincter	NN	O	I-NP	B-Medical
17	17	as	IN	O	O	O
17	18	you	PRP	O	B-NP	O
17	19	would	MD	O	B-VP	O
17	20	to	TO	O	B-VP	O
17	21	prevent	VB	O	I-VP	O
17	22	a	DT	O	B-NP	O
17	23	bowel	NN	O	I-NP	O
17	24	movement	NN	O	I-NP	O
17	25	or	CC	O	I-NP	O
17	26	urine	NN	O	I-NP	O
17	27	flow	NN	O	I-NP	O
17	28	.	.	O	O	O

18	0	They	PRP	O	B-NP	O
18	1	must	MD	O	B-VP	O
18	2	be	VB	O	I-VP	O
18	3	repeated	VBN	O	I-VP	O
18	4	several	JJ	O	B-NP	O
18	5	times	NNS	O	I-NP	O
18	6	a	DT	O	B-NP	O
18	7	day	NN	O	I-NP	B-DayFest
18	8	.	.	O	O	O

19	0	``	``	O	O	O
19	1	It	PRP	O	B-NP	O
19	2	's	VBZ	O	B-VP	O
19	3	the	DT	O	B-NP	O
19	4	patients	NNS	O	I-NP	O
19	5	who	WP	O	B-NP	O
19	6	need	VBP	O	B-VP	O
19	7	this	DT	O	B-NP	O
19	8	-LBR-	-LBR-	O	I-NP	O
19	9	Kegel	NNP	O	I-NP	O
19	10	-RBR-	-RBR-	O	I-NP	O
19	11	treatment	NN	O	I-NP	O
19	12	the	DT	O	B-NP	O
19	13	most	JJS	O	I-NP	O
19	14	who	WP	O	B-NP	O
19	15	find	VBP	O	B-VP	O
19	16	it	PRP	O	B-NP	O
19	17	the	DT	O	O	O
19	18	most	RBS	O	O	O
19	19	difficult	JJ	O	O	O
19	20	to	TO	O	B-PP	O
19	21	doCOMMA	NN	O	B-NP	O
19	22	''	''	O	O	O
19	23	Galloway	NNP	O	B-NP	B-Peop
19	24	said	VBD	O	B-VP	O
19	25	.	.	O	O	O

20	0	``	``	O	O	O
20	1	The	DT	O	B-NP	O
20	2	Neocontrol	NNP	O	I-NP	O
20	3	system	NN	O	I-NP	O
20	4	helps	VBZ	O	B-VP	O
20	5	them	PRP	O	B-NP	O
20	6	to	TO	O	B-VP	O
20	7	understand	VB	O	I-VP	O
20	8	how	WRB	O	O	O
20	9	to	TO	O	B-VP	O
20	10	work	VB	O	I-VP	O
20	11	those	DT	O	B-NP	O
20	12	muscles	NNS	O	I-NP	O
20	13	and	CC	O	O	O
20	14	keep	VB	O	B-VP	O
20	15	the	DT	O	B-NP	O
20	16	problem	NN	O	I-NP	O
20	17	from	IN	O	B-PP	O
20	18	coming	VBG	O	B-VP	O
20	19	back	RB	O	O	O
20	20	again	RB	O	O	O
20	21	.	.	O	O	O
20	22	''	''	O	O	O

21	0	Treatments	NNS	O	B-NP	O
21	1	for	IN	O	B-PP	O
21	2	incontinence	NN	O	B-NP	B-Medical
21	3	include	VBP	O	B-VP	O
21	4	collagen	NN	O	B-NP	B-Medical
21	5	injections	NNS	O	I-NP	O
21	6	to	TO	O	B-PP	O
21	7	the	DT	O	B-NP	O
21	8	urethra	NN	O	I-NP	O
21	9	COMMA	COMMA	O	O	O
21	10	probes	NNS	O	B-NP	O
21	11	to	TO	O	B-VP	O
21	12	provide	VB	O	I-VP	O
21	13	electrical	JJ	O	B-NP	O
21	14	stimulation	NN	O	I-NP	O
21	15	and	CC	O	I-NP	O
21	16	surgery	NN	O	I-NP	O
21	17	called	VBD	O	B-VP	O
21	18	a	DT	O	B-NP	O
21	19	vaginal	JJ	O	I-NP	B-Medical
21	20	repair	NN	O	I-NP	O
21	21	COMMA	COMMA	O	O	O
21	22	a	DT	O	B-NP	O
21	23	$12COMMA000-to	NN	O	I-NP	B-Money
21	24	-	:	O	O	O
21	25	$15COMMA000	NN	O	B-NP	B-Money
21	26	operation	NN	O	I-NP	O
21	27	that	WDT	O	B-NP	O
21	28	involves	VBZ	O	B-VP	O
21	29	tightening	VBG	O	I-VP	O
21	30	the	DT	O	B-NP	O
21	31	muscles	NNS	O	I-NP	O
21	32	and	CC	O	I-NP	O
21	33	ligaments	NNS	O	I-NP	O
21	34	of	IN	O	B-PP	O
21	35	the	DT	O	B-NP	O
21	36	pelvic	JJ	O	I-NP	B-Medical
21	37	floor	NN	O	I-NP	O
21	38	.	.	O	O	O

22	0	None	NN	O	B-NP	O
22	1	of	IN	O	B-PP	O
22	2	those	DT	O	B-NP	O
22	3	procedures	NNS	O	I-NP	O
22	4	works	VBZ	O	B-VP	O
22	5	for	IN	O	B-PP	O
22	6	all	DT	O	B-NP	O
22	7	women	NNS	O	I-NP	O
22	8	COMMA	COMMA	O	O	O
22	9	and	CC	O	O	O
22	10	neither	DT	O	B-NP	O
22	11	does	VBZ	O	B-VP	O
22	12	Neocontrol	NNP	O	B-NP	O
22	13	therapy	NN	O	I-NP	B-Medical
22	14	.	.	O	O	O

23	0	Galloway	NNP	O	B-NP	B-Peop
23	1	said	VBD	O	B-VP	O
23	2	it	PRP	O	B-NP	O
23	3	is	VBZ	O	B-VP	O
23	4	inappropriate	JJ	O	O	O
23	5	for	IN	O	B-PP	O
23	6	women	NNS	O	B-NP	O
23	7	who	WP	O	B-NP	O
23	8	have	VBP	O	B-VP	O
23	9	metallic	JJ	O	B-NP	O
23	10	implants	NNS	O	I-NP	O
23	11	in	IN	O	B-PP	O
23	12	their	PP$	O	B-NP	O
23	13	pelvic	JJ	O	I-NP	B-Medical
23	14	area	NN	O	I-NP	O
23	15	COMMA	COMMA	O	O	O
23	16	such	JJ	O	B-PP	O
23	17	as	IN	O	I-PP	O
23	18	a	DT	O	B-NP	O
23	19	hip	NN	O	I-NP	O
23	20	replacement	NN	O	I-NP	O
23	21	COMMA	COMMA	O	O	O
23	22	or	CC	O	B-PP	O
23	23	for	IN	O	B-PP	O
23	24	women	NNS	O	B-NP	O
23	25	who	WP	O	B-NP	O
23	26	have	VBP	O	B-VP	O
23	27	cardiac	JJ	O	B-NP	B-Medical
23	28	pacemakers	NNS	O	I-NP	O
23	29	.	.	O	O	O

24	0	In	IN	O	B-PP	O
24	1	ongoing	JJ	O	B-NP	O
24	2	clinical	JJ	O	I-NP	B-Medical
24	3	trials	NNS	O	I-NP	O
24	4	involving	VBG	O	B-VP	O
24	5	117	CD	O	B-NP	B-Num
24	6	women	NNS	O	I-NP	O
24	7	in	IN	O	B-PP	O
24	8	Cleveland	NNP	O	B-NP	B-LocCit
24	9	COMMA	COMMA	O	O	O
24	10	Chicago	NNP	O	B-NP	B-LocCit
24	11	COMMA	COMMA	O	O	O
24	12	Philadelphia	NNP	O	O	B-LocCit
24	13	and	CC	O	O	O
24	14	Orlando	NNP	O	B-NP	B-LocCit
24	15	COMMA	COMMA	O	O	O
24	16	half	DT	O	B-NP	O
24	17	of	IN	O	B-PP	O
24	18	those	DT	O	B-NP	O
24	19	who	WP	O	B-NP	O
24	20	have	VBP	O	B-VP	O
24	21	completed	VBN	O	I-VP	O
24	22	eight	CD	O	B-NP	B-Num
24	23	weeks	NNS	O	I-NP	O
24	24	of	IN	O	B-PP	O
24	25	Neocontrol	NNP	O	B-NP	O
24	26	therapy	NN	O	I-NP	B-Medical
24	27	reported	VBD	O	B-VP	O
24	28	being	VBG	O	I-VP	O
24	29	``	``	O	O	O
24	30	completely	RB	O	O	O
24	31	dry	JJ	O	O	O
24	32	.	.	O	O	O
24	33	''	''	O	O	O

25	0	Eighty-three	CD	O	B-NP	O
25	1	percent	NN	O	I-NP	O
25	2	said	VBD	O	B-VP	O
25	3	they	PRP	O	B-NP	O
25	4	had	VBD	O	B-VP	O
25	5	seen	VBN	O	I-VP	O
25	6	``	``	O	O	O
25	7	significant	JJ	O	B-NP	O
25	8	improvement	NN	O	I-NP	O
25	9	''	''	O	O	O
25	10	in	IN	O	B-PP	O
25	11	their	PP$	O	B-NP	O
25	12	incontinence	NN	O	I-NP	B-Medical
25	13	.	.	O	O	O

26	0	The	DT	O	B-NP	O
26	1	therapy	NN	O	I-NP	B-Medical
26	2	has	VBZ	O	B-VP	O
26	3	won	VBN	O	I-VP	O
26	4	raves	VBZ	O	B-VP	O
26	5	from	IN	O	B-PP	O
26	6	patients	NNS	O	B-NP	O
26	7	who	WP	O	B-NP	O
26	8	were	VBD	O	B-VP	O
26	9	helped	VBN	O	I-VP	O
26	10	in	IN	O	B-PP	O
26	11	the	DT	O	B-NP	O
26	12	clinical	JJ	O	I-NP	B-Medical
26	13	trials	NNS	O	I-NP	O
26	14	.	.	O	O	O

27	0	``	``	O	O	O
27	1	I	PRP	O	B-NP	O
27	2	've	VBP	O	B-VP	O
27	3	regained	VBN	O	I-VP	O
27	4	my	PP$	O	B-NP	O
27	5	life	NN	O	I-NP	O
27	6	in	IN	O	B-PP	O
27	7	regard	VBP	O	B-NP	O
27	8	to	TO	O	B-PP	O
27	9	sports	NNS	O	B-NP	O
27	10	and	CC	O	I-NP	O
27	11	exerciseCOMMA	NN	O	I-NP	O
27	12	''	''	O	O	O
27	13	said	VBD	O	B-VP	O
27	14	Penny	NNP	O	B-NP	B-Peop
27	15	Stockford	NNP	O	I-NP	I-Peop
27	16	COMMA	COMMA	O	O	O
27	17	45	CD	O	B-NP	B-Num
27	18	COMMA	COMMA	O	O	O
27	19	an	DT	O	B-NP	O
27	20	Orlando	NNP	O	I-NP	B-LocCit
27	21	nurse	NN	O	I-NP	B-ProfTitle
27	22	who	WP	O	B-NP	O
27	23	developed	VBD	O	B-VP	O
27	24	incontinence	NN	O	B-NP	B-Medical
27	25	after	IN	O	B-PP	O
27	26	a	DT	O	B-NP	O
27	27	hysterectomy	NN	O	I-NP	B-Medical
27	28	and	CC	O	I-NP	O
27	29	treatment	NN	O	I-NP	O
27	30	for	IN	O	B-PP	O
27	31	cancer	NN	O	B-NP	B-Medical
27	32	.	.	O	O	O

28	0	``	``	O	O	O
28	1	It	PRP	O	B-NP	O
28	2	's	VBZ	O	B-VP	O
28	3	great	JJ	O	O	O
28	4	not	RB	O	B-VP	O
28	5	having	VBG	O	I-VP	O
28	6	to	TO	O	I-VP	O
28	7	be	VB	O	I-VP	O
28	8	ever	RB	O	O	O
28	9	mindful	JJ	O	O	O
28	10	that	IN	O	O	O
28	11	I	PRP	O	B-NP	O
28	12	have	VBP	O	B-VP	O
28	13	a	DT	O	B-NP	O
28	14	leakage	NN	O	I-NP	O
28	15	problem	NN	O	I-NP	O
28	16	.	.	O	O	O

29	0	It	PRP	O	B-NP	O
29	1	's	VBZ	O	B-VP	O
29	2	a	DT	O	B-NP	O
29	3	wonderful	JJ	O	I-NP	O
29	4	feeling	NN	O	I-NP	O
29	5	to	TO	O	B-VP	O
29	6	be	VB	O	I-VP	O
29	7	that	IN	O	O	O
29	8	free	JJ	O	O	O
29	9	.	.	O	O	O
29	10	''	''	O	O	O

30	0	Story	NNP	O	O	O
30	1	Filed	NNP	O	O	O
30	2	By	IN	O	B-PP	O
30	3	Cox	NNP	O	O	O
30	4	Newspapers	NNP	O	O	O

31	0	For	IN	O	B-PP	O
31	1	Use	NN	O	B-NP	O
31	2	By	IN	O	B-PP	O
31	3	Clients	NNS	O	B-NP	O
31	4	of	IN	O	B-PP	O
31	5	the	DT	O	B-NP	O
31	6	New	NNP	O	I-NP	B-OrgCorp
31	7	York	NNP	O	I-NP	I-OrgCorp
31	8	Times	NNP	O	I-NP	I-OrgCorp
31	9	News	NNP	O	I-NP	O
31	10	Service	NNP	O	I-NP	O
